Indranil Banerjee

1.1k citations

31 papers · 892 indexed · h-index 17

Co-authors: Mahitosh Mandal Subhayan Das Bikash Chandra Jena Aditya Parekh Chandan Kanta Das Chandan Das Sujit K. Bhutia Mridula Misra
Topics: Radiopharmaceutical Chemistry and Applications (6 papers)RNA Interference and Gene Delivery (6 papers)Nanoparticle-Based Drug Delivery (5 papers)
Cited by: Cancer Research Biomaterials Pharmaceutical Science
Journals: Proceedings of the National Academy of Sciences Cancer Research Acta Biomaterialia
Partner nations: India United States United Kingdom

In The Last Decade

Indranil Banerjee

30 papers receiving 879 citations

Peers

Countries citing papers authored by Indranil Banerjee

Since Specialization

Citations

This map shows the geographic impact of Indranil Banerjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indranil Banerjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indranil Banerjee more than expected).

Fields of papers citing papers by Indranil Banerjee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Indranil Banerjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indranil Banerjee. The network helps show where Indranil Banerjee may publish in the future.

Co-authorship network of co-authors of Indranil Banerjee

This figure shows the co-authorship network connecting the top 25 collaborators of Indranil Banerjee. A scholar is included among the top collaborators of Indranil Banerjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Indranil Banerjee. Indranil Banerjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modified PAMAM Dendrimer-Based Carboplatin Delivery in Glioblastoma: In Vitro and In Vivo Studies 2025 ·ACS Applied Bio Materials ·(unknown),(unknown),Dipanjan Samanta,(unknown),(unknown),Ranabir Majumder,Indranil Banerjee,Budhaditya Mukherjee,Mahitosh Mandal	0
2	Effective approaches in conquering chemoresistance of glioblastoma: potential for nanoformulations 2025 ·Drug Delivery and Translational Research ·(unknown),Indranil Banerjee,Mahitosh Mandal	1
3	A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistance 2023 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Subhayan Das,Moumita Kundu,(unknown),Aditya Parekh,Bikash Chandra Jena,(unknown),Indranil Banerjee,Y. Rajesh,Chandan Krushna Das,Anjan K. Pradhan,Swadesh K. Das,Luni Emdad,Pralay Mitra,Paul B. Fisher,Mahitosh Mandal	6
4	Mouse Bone Marrow Cell Isolation and Macrophage Differentiation 2022 ·Methods in molecular biology ·Rachel G. Mendoza,Indranil Banerjee,(unknown),Saranya Chidambaranathan Reghupaty,Y. Rajesh,Devanand Sarkar	22
5	TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation 2022 ·Experimental Cell Research ·Bikash Chandra Jena,Chandan Kanta Das,Indranil Banerjee,(unknown),Ranabir Majumder,Subhayan Das,Angana Biswas,Moumita Kundu,Pritam Roy,Chanakya Nath Kundu,Mahitosh Mandal	36
6	Therapeutic targeting of RBPJ, an upstream regulator of ETV6 gene, abrogates ETV6-NTRK3 fusion gene transformations in glioblastoma 2022 ·Cancer Letters ·Angana Biswas,Y. Rajesh,Subhayan Das,Indranil Banerjee,Neelkamal Kapoor,Pralay Mitra,Mahitosh Mandal	8
7	Nanoparticle-mediated gene therapy as a novel strategy for the treatment of retinoblastoma 2022 ·Colloids and Surfaces B Biointerfaces ·(unknown),Indranil Banerjee,Mahitosh Mandal	15
8	Astrocyte elevated gene-1 (AEG-1): A key driver of hepatocellular carcinoma (HCC) 2021 ·Advances in cancer research ·Indranil Banerjee,Paul B. Fisher,Devanand Sarkar	7
9	Paracrine TGF-β1 from breast cancer contributes to chemoresistance in cancer associated fibroblasts via upregulation of the p44/42 MAPK signaling pathway 2021 ·Biochemical Pharmacology ·Bikash Chandra Jena,Chandan Kanta Das,Indranil Banerjee,Subhayan Das,(unknown),Ranabir Majumder,Mahitosh Mandal	41
10	Combining doxorubicin with stearylamine-bearing liposomes elicits Th1 cytokine responses and cures metastasis in a mouse model 2020 ·Cancer Immunology Immunotherapy ·(unknown),(unknown),Mohammad Asad,Indranil Banerjee,Nahid Ali	16
11	Pro-survival autophagy: An emerging candidate of tumor progression through maintaining hallmarks of cancer 2019 ·Seminars in Cancer Biology ·Chandan Kanta Das,Indranil Banerjee,Mahitosh Mandal	45
12	Targeting NFE2L2, a transcription factor upstream of MMP-2: A potential therapeutic strategy for temozolomide resistant glioblastoma 2019 ·Biochemical Pharmacology ·Y. Rajesh,Angana Biswas,(unknown),Subhayan Das,Indranil Banerjee,Payel Banik,Rashmi Bharti,(unknown),Sudip Kumar Ghosh,Mahitosh Mandal	29
13	A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes 2017 ·Molecular Therapy — Nucleic Acids ·(unknown),(unknown),Triparna Sen,Mohammad Shadab,Indranil Banerjee,(unknown),Nahid Ali	49
14	Synthesis and exploration of novel radiolabeled bombesin peptides for targeting receptor positive tumor 2017 ·Peptides ·Kakali De,Indranil Banerjee,(unknown),Shantanu Ganguly	11
15	Therapeutic implication of ‘Iturin A’ for targeting MD-2/TLR4 complex to overcome angiogenesis and invasion 2017 ·Cellular Signalling ·Goutam Dey,Rashmi Bharti,Probir Kumar Ojha,Ipsita Pal,Y. Rajesh,Indranil Banerjee,Payel Banik,Sheetal Parida,Aditya Parekh,Ramkrishna Sen,Mahitosh Mandal	33
16	Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy 2016 ·Cancer Letters ·Rashmi Bharti,Goutam Dey,Indranil Banerjee,Kaushik Dey,Sheetal Parida,B. N. Prashanth Kumar,Chandan Kanta Das,Ipsita Pal,M. Mukherjee,Mridula Misra,Anjan K. Pradhan,Luni Emdad,Swadesh K. Das,Paul B. Fisher,Mahitosh Mandal	66
17	Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy 2016 ·Acta Biomaterialia ·Indranil Banerjee,Kakali De,(unknown),Goutam Dey,Sankha Chattopadhyay,M. Mukherjee,Mahitosh Mandal,Amal Kumar Bandyopadhyay,Amit Gupta,(unknown),Mridula Misra	80
18	Radiolabeled new somatostatin analogs conjugated to DOMA chelator used as targeted tumor imaging agent: synthesis and radiobiological evaluation 2015 ·Amino Acids ·Kakali De,Indranil Banerjee,Mridula Misra	11
19	Radiolabeled novel peptide for imaging somatostatin-receptor expressing tumor: synthesis and radiobiological evaluation 2014 ·Journal of Radioanalytical and Nuclear Chemistry ·Kakali De,Ashok Behera,Indranil Banerjee,(unknown),(unknown),Mridula Misra	2
20	Synthesis, characterization, conformational analysis of a cyclic conjugated octreotate peptide and biological evaluation of 99mTc-HYNIC-His3-Octreotate as novel tracer for the imaging of somatostatin receptor-positive tumors 2012 ·Amino Acids ·Ashok Behera,Indranil Banerjee,Kakali De,(unknown),(unknown),Amalesh Samanta,(unknown),(unknown),Mridula Misra	12

About Indranil Banerjee

Indranil Banerjee is a scholar working on Biomaterials, Oncology and Toxicology, having authored 31 papers that have together received 892 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (6 papers), RNA Interference and Gene Delivery (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). The work is most often cited by research in Cancer Research (219 citations), Biomaterials (159 citations) and Pharmaceutical Science (52 citations). Indranil Banerjee has collaborated with scholars based in India, United States and United Kingdom. Frequent co-authors include Mahitosh Mandal, Subhayan Das, Bikash Chandra Jena, Aditya Parekh, Chandan Kanta Das, Chandan Das, Sujit K. Bhutia, Mridula Misra, Goutam Dey and Kakali De. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research and Acta Biomaterialia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact